Glenn Sblendorio, President & CFO, Director at Medicines Co, holds 6.20K shares in Mineralys Therapeutics, Inc. (Ticker: MLYS), holds 115.86K shares in Amicus (Ticker: FOLD), holds 0.00 shares in IVERIC bio (Ticker: ISEE).
Glenn Sblendorio latest transaction was an Uninformative Buy of ―.
What was Glenn Sblendorio's most profitable transaction?
Glenn Sblendorio’s most profitable transaction was an Informative Buy of ISEE stock on May 13, 2019. The return on the trade was 162.20%.
What is Glenn Sblendorio's role in Medicines Co?
Glenn Sblendorio's role in Medicines Co is President & CFO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.